Combination therapy with IL-15 superagonist (ALT-803) and PD-1 blockade enhances human NK cell immunotherapy against ovarian cancer
Geller, M.A., Bendzick, L.A., Ryan, C., Chu, S., Lenvik, A., Skubitz, A.P.N., Boylan, K.L.M., Isaksson Vogel, R., Miller, J., Felices, M.Volume:
145
Language:
english
Journal:
Gynecologic Oncology
DOI:
10.1016/j.ygyno.2017.03.060
Date:
June, 2017
File:
PDF, 176 KB
english, 2017